Monographie - Pentamidine isetionate

Posledná aktualizácia :
29/10/2024

Pentamidine isetionate

Chemický vzorec

Obchodný názov

Obchodné názvy sú orientačné, a zloženie pomocných látok sa môže líšiť v závislosti od krajiny a výrobcu.

DBL Pentamidine isetionate	Malajzia
Manicare	Argentína
Nebupent	Spojené štáty Americké
Pentacarinat	Belgicko, Dánsko, Fínsko, Francúzsko, Grécko, Holandsko, Kolumbia, Luxembursko, Nemecko, nový Zéland, Rakúsko, Španielsko, Švajčiarsko, Švédsko, Taliansko, Veľká Británia
Pentam	Spojené štáty Americké
Pentamidina	Argentína, Španielsko
Pentamidine isethionate	Austrália, Kanada, Malajzia, Spojené štáty Americké
Pentamina	Portugalsko

Odkazy na literatúru : Pentamidine isetionate

	Typ	Publikácia
36	Časopis	Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC. Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods. Am J Health-Syst Pharm 1995 ; 52: 2423-2426.
73	Časopis	Lor E, Takagi J. Visual compatibility of foscarnet with other injectable drugs. Am J Hosp Pharm 1990 ; 47: 157-159.
198	Časopis	Gayed AA, Kheshary PR, Hinkle RL. Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection. Am J Health-Syst Pharm 1995 ; 52: 516-520.
275	Časopis	Lewis JD, El-Gendy A. Cephalosporin-pentamidine isethionate incompatibilities. Am J Health-Syst Pharm 1996 ; 53: 1461-1462.
337	Časopis	Bashaw ED, Amantea MA, Minor JR, Galleli JF. Visual compatibility of zidovudine with other drugs during simulated Y-site administration. Am J Hosp Pharm 1988 ; 45: 2532-2533.
424	Časopis	De NC, Alam AS, Kapoor JN. Stability of pentamidine isethionate in 5% dextrose and 0.9% sodium chloride injections. Am J Hosp Pharm 1986 ; 43: 1486-1488.
496	Časopis	Lor E, Sheybani T, Takagi J. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1991 ; 48: 744-746.
604	Laboratórium	Stabilité des médicaments dans l'Intermate® SV50, 100, 200 Baxter 1998
1135	Časopis	Baltz JK, Kennedy P, Minor JR, Gallelli J. Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration. Am J Hosp Pharm 1990 ; 47: 2075-2077.
1235	Časopis	Leigh PH, Buddle GC. Pentamidine infusion stability. Br J Pharm Pract 1988 ; 10: 22-23.
1625	Časopis	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1925	Časopis	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
3543	Laboratórium	Ceftazidime – Summary of Product Characteristics Wockhardt 2013
3559	Laboratórium	Pentamidine diiséthionate (Pentacarinat®) - Résumé des caractéristiques du produit Sanofi Aventis France 2013
3560	Laboratórium	Linezolid (Zyvox®) - Summary of Product Characteristics Pharmacia 2013
3662	Laboratórium	Foscavir (Foscarnet®) - Summary of Product Characteristics Clinigen 2014

Mentions Légales